Other
Pre-Tax Income (Foreign)
Insmed Pre-Tax Income (Foreign) remained flat by 0.0% to -$38.31M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 60.4%, from -$23.88M to -$38.31M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income (Foreign) shows a downward trend with a 15.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
First reportedQ1 2015
Last reportedQ4 2025Feb 19, 2026
Metric ID:
other_income_loss_from_continuing_operations_before_inco_87608bHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$87.57M | -$73.89M | -$80.83M | -$95.53M | -$153.26M |
| YoY Change | — | +15.6% | -9.4% | -18.2% | -60.4% |
Range-$153.26M – -$73.89M
CAGR+15.0%
Avg YoY Growth-18.1%
Median YoY Growth-13.8%
Current Streak3 years decline
Pre-Tax Income (Foreign) at Other Companies
Frequently Asked Questions
- What is Insmed's pre-tax income (foreign)?
- Insmed (INSM) reported pre-tax income (foreign) of -$38.31M in Q4 2025.
- How has Insmed's pre-tax income (foreign) changed year-over-year?
- Insmed's pre-tax income (foreign) decreased by 60.4% year-over-year, from -$23.88M to -$38.31M.
- What is the long-term trend for Insmed's pre-tax income (foreign)?
- Over 4 years (2021 to 2025), Insmed's pre-tax income (foreign) has grown at a 15.0% compound annual growth rate (CAGR), from -$87.57M to -$153.26M.